Notas de Prensa
-
abr. 27, 2022Influenza y Vacunación16 06 2020 • PDFSanofi invests to make France its world class center of excellence in vaccine research and production25 05 2020 • PDFSanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration24 04 2020 • PDFFDA approves MenQuadfiTM , the latest innovation in meningococcal (MenACWY) vaccination14 04 2020 • PDFSanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-1903 04 2020 • PDFAvailability of the Pre-quarterly Results Communication03 04 2020 • PDFDupixent® (dupilumab) Phase 3 data show significant improvement in severe atopic dermatitis for children aged 6 to 11 years27 03 2020 • PDFSanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19
Estás a punto de salir de Sanofi Venezuela
Estás a punto de visitar otro sitio web de Sanofi.
¿Quieres continuar?